Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Smith & Nephew Snats ADR (SNN)

Smith & Nephew Snats ADR (SNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,514,795
  • Shares Outstanding, K 437,160
  • Annual Sales, $ 5,549 M
  • Annual Income, $ 263,000 K
  • 60-Month Beta 0.74
  • Price/Sales 2.05
  • Price/Cash Flow 8.04
  • Price/Book 2.17
Trade SNN with:

Options Overview Details

View History
  • Implied Volatility 31.81% ( -6.97%)
  • Historical Volatility 24.86%
  • IV Percentile 39%
  • IV Rank 38.22%
  • IV High 70.03% on 10/11/23
  • IV Low 8.17% on 12/05/23
  • Put/Call Vol Ratio 107.33
  • Today's Volume 325
  • Volume Avg (30-Day) 48
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 486
  • Open Int (30-Day) 1,192

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.43 +1.00%
on 03/28/24
28.15 -8.74%
on 03/12/24
-0.74 (-2.80%)
since 02/28/24
3-Month
25.43 +1.00%
on 03/28/24
28.93 -11.20%
on 02/22/24
-1.62 (-5.93%)
since 12/28/23
52-Week
21.52 +19.35%
on 10/27/23
33.08 -22.35%
on 04/28/23
-2.12 (-7.62%)
since 03/28/23

Most Recent Stories

More News
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports...

SNN : 25.58 (-2.89%)
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

/CNW/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine,...

SNN : 25.58 (-2.89%)
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.

BSX : 68.63 (+0.01%)
CNC : 78.39 (+0.05%)
HUM : 348.40 (-0.31%)
ISRG : 399.10 (-0.25%)
THC : 105.13 (+0.25%)
UNH : 492.80 (-0.06%)
SGRY : 29.99 (+0.17%)
ZBH : 132.44 (-0.13%)
ELV : 520.69 (+0.14%)
HCA : 331.86 (+0.05%)
SNN : 25.58 (-2.89%)
Smith+Nephew announces 510(k) clearance of its AETOSâ„¢ Shoulder System for anatomic and reverse shoulder replacement

/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States...

SNN : 25.58 (-2.89%)
Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty

/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORIâ„¢ Digital Tensioner - a purpose built...

SNN : 25.58 (-2.89%)
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

PAHC : 13.15 (+0.69%)
SNN : 25.58 (-2.89%)
3 Healthcare Dividend Payers With Big Price Growth

Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers. 

SNY : 49.21 (-0.67%)
AZN : 68.07 (-0.28%)
SNN : 25.58 (-2.89%)
Stocks Move Higher Before the Open as Market Sentiment Improves, U.S. Inflation Data on Tap

June S&P 500 futures (ESM23) are up +0.21%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.28% this morning as market participants continued to assess the path of Federal Reserve monetary policy...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
CAT : 365.17 (+0.14%)
WDC : 68.74 (+1.63%)
MU : 118.65 (-0.41%)
AAPL : 171.00 (-1.33%)
JPM : 199.77 (+0.13%)
WFC : 57.97 (+0.62%)
C : 63.17 (+0.67%)
CINE.LN : 0.381 (unch)
TLRY : 2.60 (+4.84%)
HEXO : 0.7100 (+2.45%)
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

SNN : 25.58 (-2.89%)
VREX : 18.22 (+3.35%)
Smith & Nephew's (SNN) CIT Technology Favored by New Study

Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.

SNN : 25.58 (-2.89%)
HAE : 83.96 (-0.15%)
CPRX : 16.20 (-0.43%)
AVNS : 20.07 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Key Turning Points

3rd Resistance Point 26.83
2nd Resistance Point 26.67
1st Resistance Point 26.51
Last Price 25.58
1st Support Level 26.19
2nd Support Level 26.03
3rd Support Level 25.87

See More

52-Week High 33.08
Fibonacci 61.8% 28.67
Fibonacci 50% 27.31
Fibonacci 38.2% 25.94
Last Price 25.58
52-Week Low 21.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar